To date, several factors, such as hepatocyte growth factor and Klotho, have been reported to have a therapeutic potential for renal fibrosis by reducing fibrogenic cytokine production as well as fibronectin and type I collagen deposition (Dai et al., 2004; Satoh et al., 2012). The gene discussed is KL; the disease is renal fibrosis.